Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | TGM2 | P21980 | 1/20 | 0.32 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.32 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL11742981 | 0.98 | TSHR (0.45) | TSHRCYP2C19TGM2ZDHHC20ZDHHC2 | |
| SCHEMBL19499070 | 0.93 | TSHR (0.41) | TSHR | |
| SCHEMBL18912736 | 0.83 | TSHR (0.45) | TSHRCYP2C19TGM2ZDHHC20ZDHHC2 | |
| SCHEMBL1994296 | 0.83 | TSHR (0.50) | TSHRCYP2C19TGM2ZDHHC20ZDHHC2 | |
| SCHEMBL26026748 | 0.81 | TSHR (0.44) | TSHRCYP2C19TGM2ZDHHC20ZDHHC2 | |
| SCHEMBL11545939 | 0.79 | TSHR (0.41) | TSHRCYP2C19ZDHHC20ZDHHC2ALDH1A1 | |
| SCHEMBL21281463 | 0.76 | TSHR (0.39) | TSHRTGM2ZDHHC20ZDHHC2ALDH1A1 | |
| Acrylic Acid SCHEMBL8742887 | 0.76 | TSHR (0.39) | TSHRTGM2 | |
| SCHEMBL11742079 | 0.75 | POLB (0.30) | — | |
| SCHEMBL1282258 | 0.74 | TSHR (0.48) | TSHRCYP2C19TGM2ZDHHC20ZDHHC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4600057-A | Method of reducing the permeability of a subterranean formation | HALLIBURTON COMPANY (US) | 1986-07-15 | — | — | US | claimed |
| EP-0180406-A2 | Method of treating a subterranean formation | HALLIBURTON COMPANY (US) | 1986-05-07 | — | — | EP | claimed |
| US-RE30142-E | FOR LUBRICANTS | THE LUBRIZOL CORPORATION (US) | 1979-11-06 | — | — | US | claimed |
| US-20230347333-A1 | Membranes | FUJIFILM CORPORATION (JP) | 2023-11-02 | — | — | US | disclosed |
| US-20230347333-A1 | Membranes | FUJIFILM CORPORATION (JP) | 2023-11-02 | — | — | US | disclosed |
| US-20230311071-A1 | Composite Membrane | FUJIFILM MANUFACTURING EUROPE B.V. (NL) | 2023-10-05 | — | — | US | disclosed |
| US-20230311071-A1 | Composite Membrane | FUJIFILM MANUFACTURING EUROPE B.V. (NL) | 2023-10-05 | — | — | US | disclosed |
| US-20230028028-A1 | Affinity Membranes, Compounds, Compositions and Processes for Their Preparation and Use | FUJIFILM MANUFACTURING EUROPE B.V. (NL) | 2023-01-26 | — | — | US | disclosed |
| WO-2022122931-A1 | PURIFYING POLAR LIQUIDS | FUJIFILM MANUFACTURING EUROPE BV (NL) | 2022-06-16 | — | — | WO | disclosed |
| EP-3245234-B1 | CURABLE COMPOSITIONS AND MEMBRANES | FUJIFILM MFG EUROPE BV (NL) | 2019-08-21 | — | — | EP | disclosed |
| US-10336873-B2 | Functional polymer membrane, manufacturing method therefor, ion exchange membrane and proton conductive membrane equipped with functional polymer membrane, and ion exchange device | FUJIFILM CORPORATION (JP) | 2019-07-02 | — | — | US | disclosed |
| US-4960761-A | High surface area polymers of pyrrole or copolymers of pyrrole | THE LUBRIZOL CORPORATION (US) | 1990-10-02 | — | — | US | disclosed |
| US-4921890-A | Process for improving polymer substrate properties, and flame retardancy modified polymers produced thereby | INTERA COMPANY, LTD. (US) | 1990-05-01 | — | — | US | disclosed |
| US-4839322-A | ELECTROCONDUCTIVE SURFACE; CATALYST | THE LUBRIZOL CORPORATION (US) | 1989-06-13 | — | — | US | disclosed |
| EP-0294531-A2 | Treatment of polymer substrates | Intera Company, Ltd (US) | 1988-12-14 | — | — | EP | disclosed |
| US-4791374-A | IN LUBRICATING OIL OF INTERNAL COMBUSTION AND DIESEL ENGINES USING AN ELECTROCONDUCTIVE POLYMER | THE LUBRIZOL CORPORATION (US) | 1988-12-13 | — | — | US | disclosed |
| US-4726968-A | EMULSION POLYMERIZATION OF WATER-SOLUBLE CROSSLINKING VINYL MONOMER | INTERA COMPANY, LTD., A TENNESSEE LIMITED PARTNERSHIP (US) | 1988-02-23 | — | — | US | disclosed |
| US-4600057-A | Method of reducing the permeability of a subterranean formation | HALLIBURTON COMPANY (US) | 1986-07-15 | — | — | US | disclosed |
| EP-0180406-A2 | Method of treating a subterranean formation | HALLIBURTON COMPANY (US) | 1986-05-07 | — | — | EP | disclosed |
| US-4034001-A | MONOMERS | THE LUBRIZOL CORPORATION (US) | 1977-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230028028-A1 | Affinity Membranes, Compounds, Compositions and Processes for Their Preparation and Use | MLEC, PGRMC1, PICALM | TSHR 4773/4885CYP2C19 2692/4885TGM2 2349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.